The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 4,120,000 | 2,000,000 | SH | SOLE | 0 | 0 | 2,000,000 | ||
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 4,182,002 | 4,100,002 | SH | SOLE | 0 | 0 | 4,100,002 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 16,387,500 | 14,250,000 | SH | SOLE | 0 | 0 | 14,250,000 | ||
ADVERUM BIOTECHNOLOGIES INC | COM NEW | 00773U207 | 15,921,809 | 2,268,064 | SH | SOLE | 0 | 0 | 2,268,064 | ||
ALLOVIR INC | COM | 019818103 | 487,595 | 603,086 | SH | SOLE | 0 | 0 | 603,086 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 6,151,892 | 5,749,432 | SH | SOLE | 0 | 0 | 5,749,432 | ||
ASTROTECH CORP | COM | 046484309 | 1,761,076 | 220,410 | SH | SOLE | 0 | 0 | 220,410 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 22,277,500 | 6,650,000 | SH | SOLE | 0 | 0 | 6,650,000 | ||
LISATA THERAPEUTICS INC | COM | 128058302 | 854,007 | 284,669 | SH | SOLE | 0 | 0 | 284,669 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 3,014,045 | 2,093,232 | SH | SOLE | 0 | 0 | 2,093,232 | ||
FORTE BIOSCIENCES INC | COM NEW | 34962G208 | 393,916 | 70,468 | SH | SOLE | 0 | 0 | 70,468 | ||
CALCIMEDICA INC | COM NEW | 38942Q202 | 681,719 | 153,887 | SH | SOLE | 0 | 0 | 153,887 | ||
HILLEVAX INC | COM | 43157M102 | 34,778 | 19,760 | SH | SOLE | 0 | 0 | 19,760 | ||
IKENA ONCOLOGY INC | COM | 45175G108 | 1,251,288 | 723,288 | SH | SOLE | 0 | 0 | 723,288 | ||
INSTIL BIO INC | COM NEW | 45783C200 | 22,552,200 | 335,000 | SH | SOLE | 0 | 0 | 335,000 | ||
ISHARES TR | 0-3 MNTH TREASRY | 46436E718 | 27,194,400 | 270,000 | SH | SOLE | 0 | 0 | 270,000 | ||
LENZ THERAPEUTICS INC | COM | 52635N103 | 1,424,400 | 60,000 | SH | SOLE | 0 | 0 | 60,000 | ||
MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | 1,726,858 | 1,136,091 | SH | SOLE | 0 | 0 | 1,136,091 | ||
NEXTCURE INC | COM | 65343E108 | 378,757 | 276,465 | SH | SOLE | 0 | 0 | 276,465 | ||
ORAMED PHARMACEUTICALS INC | COM NEW | 68403P203 | 5,334,306 | 2,186,191 | SH | SOLE | 0 | 0 | 2,186,191 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 2,516,270 | 1,688,772 | SH | SOLE | 0 | 0 | 1,688,772 | ||
PIERIS PHARMACEUTICALS INC | COM NEW | 720795202 | 698,515 | 42,130 | SH | SOLE | 0 | 0 | 42,130 | ||
RENEO PHARMACEUTICALS INC | COM | 75974E103 | 5,877,572 | 3,457,395 | SH | SOLE | 0 | 0 | 3,457,395 | ||
SPDR SER TR | BLOOMBERG 1-3 MO | 78468R663 | 16,066,750 | 175,000 | SH | SOLE | 0 | 0 | 175,000 | ||
TALIS BIOMEDICAL CORP | COM NEW | 87424L207 | 460,099 | 248,702 | SH | SOLE | 0 | 0 | 248,702 | ||
TECTONIC THERAPEUTIC INC | COM | 878972108 | 6,416,086 | 211,752 | SH | SOLE | 0 | 0 | 211,752 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 1,071,665 | 228,500 | SH | SOLE | 0 | 0 | 228,500 | ||
VERRICA PHARMACEUTICALS INC | COM | 92511W108 | 261,000 | 180,000 | SH | SOLE | 0 | 0 | 180,000 | ||
VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 451,500 | 150,000 | SH | SOLE | 0 | 0 | 150,000 |